Why Intellia Therapeutics Inc (NASDAQ: NTLA) At $24.46 Is Worth Your Money?

Intellia Therapeutics Inc (NASDAQ:NTLA) does about 1.49M shares in volume on a normal day but saw 2041878 shares change hands in Friday’s trading. The company now has a market cap of 2.36B USD. Its current market price is $24.46, marking a decrease of -1.61% compared to the previous close of $24.86. The 52 week high reached by this stock is $47.48 whilst the lowest price level in 52 weeks is $19.37.

Intellia Therapeutics Inc (NTLA) has a 20-day trading average at $22.35 and the current price is -48.48% off the 52-week high compared with 26.28% distance from its 52-week low. The 50-day simple moving average of the closing price is $25.44 and its 200-day simple moving average is $29.61. If we look at the stock’s price movements over the week, volatility stands at 4.51%, which increases to 5.24% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 54.73 to suggest the stock is neutral.

The consensus objective for the share price is $68.17, suggesting that the stock has a potential upside of 64.12% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 23, 2024 when Goldman downgraded the stock to “Neutral” and issued a price target of between $136 and $32. Canaccord Genuity initiated its price target at $66.

Intellia Therapeutics Inc (NTLA) stock is up 3.64% over the week and -2.20% over the past month. Its price is -19.78% year-to-date and -45.87% over the past year.

To reach the target analysts have set, the stock logically needs to grow 64.12 percent from here.

The company has a return on investment of -43.03% and return on equity of -43.60%. The beta has a value of 1.87. Price to book ratio is 2.27 and price to sales ratio is 44.85.